Studies in solid tumors, such as gastric cancers, pancreatic cancers and renal carcinomas, have found high expression of IL-32, suggesting that this cytokine is an independent prognostic factor [19–21]. The gene discussed is IL32; the disease is familial pancreatic carcinoma.